PolyPid
PYPD
PYPD
27 hedge funds and large institutions have $4.95M invested in PolyPid in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.02% less ownership
Funds ownership: 0.2% → 0.18% (-0.02%)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
Holders
27
Holding in Top 10
–
Calls
$686K
Puts
$175K
Top Buyers
| 1 | +$87K | |
| 2 | +$69.7K | |
| 3 | +$49.4K | |
| 4 |
Morgan Stanley
New York
|
+$26.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.28K |
Top Sellers
| 1 | -$263K | |
| 2 | -$94.8K | |
| 3 | -$72K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$37.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$27.8K |